[Retracted] FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway

Figure 3

FSCN1 promotes glycolysis in prostate cancer cells. (a–d) Determination of the glucose consumption (a), lactate production (b), ECAR (c), and extracellular pH (d) in PC-3 cells in the si-NC, si-FSCN1#1, and si-FSCN1#2 groups, and vs si-NC; E-H, assay of the glucose consumption (e), lactate production (f), ECAR (g), and extracellular pH in DU145 cells in the mock group and the FSCN1 group (h), .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)